Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

China flag China · Delayed Price · Currency is CNY
29.55
-0.62 (-2.06%)
At close: Mar 9, 2026
29.83%
Market Cap 1.71B
Revenue (ttm) 174.00M
Net Income (ttm) -49.88M
Shares Out 55.19M
EPS (ttm) -0.90
PE Ratio n/a
Forward PE n/a
Dividend 0.34 (1.15%)
Ex-Dividend Date Oct 24, 2025
Volume 860,577
Average Volume 696,451
Open 29.87
Previous Close 30.17
Day's Range 28.85 - 29.97
52-Week Range 17.50 - 36.00
Beta 0.38
RSI 46.24
Earnings Date Apr 11, 2026

About SHA:688217

Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases in China. The company offers self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma. Shanghai Rightongene Biotechnology Co., Ltd. was founded in 2012 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 385
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688217
Full Company Profile

Financial Performance

In 2025, SHA:688217's revenue was 174.00 million, a decrease of -28.19% compared to the previous year's 242.31 million. Losses were -49.88 million, 216.4% more than in 2024.

Financial Statements

News

There is no news available yet.